Factors Impacting the Immunogenicity of Etrolizumab & Clinical Consequences., PMID:40481373
Repeated HLA-DRB1 and HLA-DQB1 Mismatches Without Preformed DSA Affect Graft Survival, Rejection and DSA Development: A Multicenter Analysis., PMID:40387242
Computational Immunogenetic Analysis of Botulinum Toxin A Immunogenicity and HLA Gene Haplotypes: New Insights., PMID:40278680
Evaluating the Antigen and Eplet Accuracy of DQA1 Imputations With the HaploSFHI Two-Field HLA Typing Inference Tool., PMID:40269614
The Prospective Registry of MyositIS (PROMIS): I. Next-generation sequencing identifies HLA-DQA1 as a novel genetic risk of anti-MDA5 antibody-positive dermatomyositis., PMID:40246682
From genetic variants to therapeutic targets: insights into understanding rheumatoid arthritis., PMID:40236704
Variations in de novo donor-specific antibody development among HLA-DQ mismatches in kidney transplant recipients., PMID:40233060
A Potential Link Between HLA-DRB1/DQB1 Alleles and Response to Treatment in Rheumatoid Arthritis Patients., PMID:40195278
Association between HLA-DRB1*04, HLA-DQB1*03, and HLA-DQB1*06 with alloimmunization in transfusion-dependent patients with thalassemia: the first case-control study in Iran., PMID:40100392
HLA Association With AQP4-IgG-Positive Neuromyelitis Optica Spectrum Disorder in the Korean Population., PMID:40020215
Insulitis and exocrinitis in autoantibody-positive non-diabetic individuals: role of HLA genotypes., PMID:39873482
The Clinical Significance of HLA Compatibility Scores in Lung Transplantation., PMID:39829718
Evaluation of anti-SARS-CoV-2 RBD antibody response after booster dose of SpikoGen® in individuals with two previous doses of Sinopharm and its association with HLA-DR and -DQ alleles., PMID:39764935
Ofatumumab treatment in new-onset narcolepsy type 1 following SARS-CoV-2 infection., PMID:39729629
Enriched class II HLA inherence in patients with checkpoint inhibitor-associated bullous pemphigoid., PMID:39592443
Characteristics of Type 1 Diabetes Among Patients Carrying the Protective HLA-DQB1*06:02 Allele., PMID:39564779
Genetic Analysis of Asymptomatic Antinuclear Antibody Production., PMID:39420706
High-Risk HLA-DQ Mismatches Are Associated With Adverse Outcomes After Lung Transplantation., PMID:39381015
Relationship between HLA-II Gene Polymorphisms and Immune Response in COVID-19 Survivors and Volunteers Vaccinated against This Infection., PMID:39340619
Genetic analysis of asymptomatic antinuclear antibody production., PMID:39281743
Potential contribution of gut microbiota in the development of autoantibodies in T1D children carrying HLA-DRB1/DQB1 risk alleles: an experimental and in silico analysis., PMID:39276210
Sustained HIV remission after allogeneic hematopoietic stem cell transplantation with wild-type CCR5 donor cells., PMID:39222660
Genetic association of antinuclear antibodies with HLA in JIA patients: a Swedish cohort study., PMID:39187888
Effects of Teprotumumab and Role of Human Leukocyte Antigens Markers in Patients With Thyroid Eye Disease., PMID:39187158
Identification of HLA alleles involved in immune thrombotic thrombocytopenic purpura patients from Turkey., PMID:39083057
IgLON5-IgG: Innocent Bystander or Perpetrator?, PMID:39063198
HLA Mismatches Identified by a Novel Algorithm Predict Risk of Antibody-mediated Rejection From De Novo Donor-specific Antibodies., PMID:39049137
High-resolution HLA sequencing and hypocretin receptor 2 autoantibodies in narcolepsy type 1 and type 2., PMID:38898624
Case report: Strong GAD antibody positivity and type 1 diabetes-HLA-susceptible haplotype-DRB1*04:05-DQB1*04:01 in a Japanese patient with immune checkpoint inhibitor-induced type 1 diabetes., PMID:38841300
Homozygosity in any HLA locus is a risk factor for specific antibody production: the taboo concept 2.0., PMID:38840925
Relationship between HLA genetic variations, COVID-19 vaccine antibody response, and risk of breakthrough outcomes., PMID:38740772
Multiple polygenic risk scores can improve the prediction of systemic lupus erythematosus in Taiwan., PMID:38724181
Recurrence of Idiopathic Membranous Nephropathy in the Kidney Allograft: A Systematic Review., PMID:38672095
Multi-omics study reveals different pathogenesis of the generation of skin lesions in SLE and IDLE patients., PMID:38643729
The influence of HLA allele and haplotype on RhE alloimmunization among pregnant females in the Chinese Han population., PMID:38637118
Impact of human leucocyte antigen class II polymorphism on anti-red blood cell antibody development: Correlations and indications., PMID:38596887
Human leukocyte antigen variants associate with BNT162b2 mRNA vaccine response., PMID:38575714
Pathologic Features of Anti-Ku Myositis., PMID:38547417
HLA allele frequency of HLA-A, -B, -C, -DRB1 and -DQB1 in Indian recurrent implantation failure and recurrent pregnancy loss couples - A retrospective study., PMID:38518419
Shared and distinct genetics of pure type 1 diabetes and type 1 diabetes with celiac disease, homology in their auto-antigens and immune dysregulation states: a study from North India., PMID:38483572
Longitudinal screening of HLA-risk and HLA-nonrisk children for celiac disease to age 15 years: CiPiS study., PMID:38477348
Thyroid autoimmunity in relation to HLA-DRB1 and HLA-DQB1 polymorphism in nonsegmental vitiligo: a cross-sectional-study., PMID:38463584
Exploration of potential immune mechanisms in cervical dystonia., PMID:38462403
Coexistence of anti-NMDAR and anti-IgLON5 antibodies in an autoimmune encephalitis patient: The first case report., PMID:38449620
HLA-DQB1*05 subtypes and not DRB1*10:01 mediates risk in anti-IgLON5 disease., PMID:38425314
DQB1 antigen matching improves rejection-free survival in pediatric heart transplant recipients., PMID:38232791
The genome-wide association study of serum IgE levels demonstrated a shared genetic background in allergic diseases., PMID:38199299
Transfusion-Related acute lung injury (TRALI) caused by antibodies to HLA-DRB1* 07:01 and HLA-DQB1*02:02: A case report., PMID:38107079
High maternal-fetal HLA eplet compatibility is associated with severe manifestation of preeclampsia., PMID:38022600
Role of Human Leukocyte Antigen Class II in Antibody-Mediated Skin Disorders., PMID:38003999
For research use only. Not for human or drug use.
